| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | ZMPSTE24 ERAP1 REN CAPN13 PLAU MMP10 TMPRSS7 CTSD USP48 CTSV CTSO | 8.47e-06 | 430 | 98 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidase activity | ZMPSTE24 ERAP1 PARK7 REN CAPN13 PLAU MMP10 TMPRSS7 CTSD USP48 CTSV CTSO USP47 | 1.85e-05 | 654 | 98 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 6.53e-05 | 86 | 98 | 5 | GO:0004197 | |
| GeneOntologyMolecularFunction | collagen fibril binding | 7.13e-05 | 3 | 98 | 2 | GO:0098633 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 3.70e-04 | 192 | 98 | 6 | GO:0008234 | |
| GeneOntologyCellularComponent | blood microparticle | 8.39e-05 | 144 | 104 | 6 | GO:0072562 | |
| Domain | CUB | 1.21e-04 | 49 | 97 | 4 | PF00431 | |
| Domain | CUB | 1.31e-04 | 50 | 97 | 4 | SM00042 | |
| Domain | - | 1.53e-04 | 52 | 97 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.65e-04 | 53 | 97 | 4 | PS01180 | |
| Domain | CUB_dom | 2.19e-04 | 57 | 97 | 4 | IPR000859 | |
| Domain | THIOL_PROTEASE_CYS | 3.24e-04 | 26 | 97 | 3 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 3.63e-04 | 27 | 97 | 3 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 3.63e-04 | 27 | 97 | 3 | PS00639 | |
| Domain | MACPF_CS | 3.95e-04 | 6 | 97 | 2 | IPR020863 | |
| Domain | MACPF_2 | 5.51e-04 | 7 | 97 | 2 | PS51412 | |
| Domain | MACPF_1 | 5.51e-04 | 7 | 97 | 2 | PS00279 | |
| Domain | Aspartic_peptidase_N | 5.51e-04 | 7 | 97 | 2 | IPR012848 | |
| Domain | A1_Propeptide | 5.51e-04 | 7 | 97 | 2 | PF07966 | |
| Domain | RRM | 9.42e-04 | 217 | 97 | 6 | SM00360 | |
| Domain | LDLR_class-A_CS | 1.17e-03 | 40 | 97 | 3 | IPR023415 | |
| Domain | Aspartic_peptidase_A1 | 1.17e-03 | 10 | 97 | 2 | IPR001461 | |
| Domain | L27_C | 1.17e-03 | 10 | 97 | 2 | IPR014775 | |
| Domain | MAC_perforin | 1.17e-03 | 10 | 97 | 2 | IPR001862 | |
| Domain | L27 | 1.17e-03 | 10 | 97 | 2 | PF02828 | |
| Domain | PEPTIDASE_A1 | 1.17e-03 | 10 | 97 | 2 | IPR033121 | |
| Domain | Asp | 1.17e-03 | 10 | 97 | 2 | PF00026 | |
| Domain | PEPTIDASE_A1 | 1.17e-03 | 10 | 97 | 2 | PS51767 | |
| Domain | RRM_dom | 1.19e-03 | 227 | 97 | 6 | IPR000504 | |
| Domain | RRM | 1.27e-03 | 230 | 97 | 6 | PS50102 | |
| Domain | EGF_3 | 1.42e-03 | 235 | 97 | 6 | PS50026 | |
| Domain | Pept_his_AS | 1.42e-03 | 11 | 97 | 2 | IPR025660 | |
| Domain | DUF1220 | 1.42e-03 | 11 | 97 | 2 | PF06758 | |
| Domain | MACPF | 1.42e-03 | 11 | 97 | 2 | PF01823 | |
| Domain | NBPF_dom | 1.42e-03 | 11 | 97 | 2 | IPR010630 | |
| Domain | NBPF | 1.42e-03 | 11 | 97 | 2 | PS51316 | |
| Domain | Ldl_recept_a | 1.65e-03 | 45 | 97 | 3 | PF00057 | |
| Domain | - | 1.70e-03 | 12 | 97 | 2 | 2.40.70.10 | |
| Domain | MACPF | 1.70e-03 | 12 | 97 | 2 | IPR020864 | |
| Domain | MACPF | 1.70e-03 | 12 | 97 | 2 | SM00457 | |
| Domain | Znf_C2H2_matrin | 1.70e-03 | 12 | 97 | 2 | IPR000690 | |
| Domain | ASP_PROTEASE | 1.70e-03 | 12 | 97 | 2 | PS00141 | |
| Domain | - | 1.72e-03 | 244 | 97 | 6 | 3.30.70.330 | |
| Domain | - | 1.75e-03 | 46 | 97 | 3 | 4.10.400.10 | |
| Domain | EGF-like_dom | 1.90e-03 | 249 | 97 | 6 | IPR000742 | |
| Domain | LDLRA_1 | 1.98e-03 | 48 | 97 | 3 | PS01209 | |
| Domain | Kelch_2 | 2.01e-03 | 13 | 97 | 2 | IPR011498 | |
| Domain | L27 | 2.01e-03 | 13 | 97 | 2 | SM00569 | |
| Domain | L27 | 2.01e-03 | 13 | 97 | 2 | PS51022 | |
| Domain | L27_dom | 2.01e-03 | 13 | 97 | 2 | IPR004172 | |
| Domain | Kelch_2 | 2.01e-03 | 13 | 97 | 2 | PF07646 | |
| Domain | Pept_C1 | 2.01e-03 | 13 | 97 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 2.01e-03 | 13 | 97 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 2.01e-03 | 13 | 97 | 2 | PF00112 | |
| Domain | Aspartic_peptidase_AS | 2.01e-03 | 13 | 97 | 2 | IPR001969 | |
| Domain | Peptidase_C1A | 2.01e-03 | 13 | 97 | 2 | IPR013128 | |
| Domain | LDrepeatLR_classA_rpt | 2.10e-03 | 49 | 97 | 3 | IPR002172 | |
| Domain | LDLa | 2.10e-03 | 49 | 97 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.10e-03 | 49 | 97 | 3 | PS50068 | |
| Domain | EGF_1 | 2.14e-03 | 255 | 97 | 6 | PS00022 | |
| Domain | Nucleotide-bd_a/b_plait | 2.27e-03 | 258 | 97 | 6 | IPR012677 | |
| Domain | EGF-like_CS | 2.41e-03 | 261 | 97 | 6 | IPR013032 | |
| Domain | EGF_2 | 2.59e-03 | 265 | 97 | 6 | PS01186 | |
| Domain | Guanylate_kinase_CS | 3.06e-03 | 16 | 97 | 2 | IPR020590 | |
| Domain | MAM_1 | 3.06e-03 | 16 | 97 | 2 | PS00740 | |
| Domain | FKBP_PPIASE | 3.06e-03 | 16 | 97 | 2 | PS50059 | |
| Domain | FKBP_C | 3.06e-03 | 16 | 97 | 2 | PF00254 | |
| Domain | MAM | 3.45e-03 | 17 | 97 | 2 | SM00137 | |
| Domain | PPIase_FKBP | 3.45e-03 | 17 | 97 | 2 | IPR023566 | |
| Domain | Peptidase_aspartic_dom | 3.45e-03 | 17 | 97 | 2 | IPR021109 | |
| Domain | MAM | 3.87e-03 | 18 | 97 | 2 | PF00629 | |
| Domain | MAM_dom | 3.87e-03 | 18 | 97 | 2 | IPR000998 | |
| Domain | ZF_MATRIN | 3.87e-03 | 18 | 97 | 2 | PS50171 | |
| Domain | MAM_2 | 3.87e-03 | 18 | 97 | 2 | PS50060 | |
| Domain | Fibrinogen_CS | 4.31e-03 | 19 | 97 | 2 | IPR020837 | |
| Domain | RRM_1 | 4.60e-03 | 208 | 97 | 5 | PF00076 | |
| Domain | PPIase_FKBP_dom | 4.77e-03 | 20 | 97 | 2 | IPR001179 | |
| Pubmed | 3.43e-11 | 21 | 105 | 6 | 16079250 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | AMBP ZMPSTE24 RARS1 PARK7 ANXA11 CP NEB CEMIP2 FAT1 ATP6V1D FGA C9 RAB21 CTSD SPEN | 4.17e-07 | 1016 | 105 | 15 | 19056867 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L ZMPSTE24 ERAP1 FKBP9 NBPF26 GDE1 CEMIP2 NRP1 FAT1 P4HA1 RAB21 CTSD USP48 SUCO PLS3 FKBP14 | 6.46e-07 | 1201 | 105 | 16 | 35696571 |
| Pubmed | The human plasma proteome: a nonredundant list developed by combination of four separate sources. | 7.33e-07 | 165 | 105 | 7 | 14718574 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 8.96e-07 | 170 | 105 | 7 | 23314748 | |
| Pubmed | 1.20e-06 | 257 | 105 | 8 | 16335952 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 3.16e-06 | 10 | 105 | 3 | 22973535 | |
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 7504460 | ||
| Pubmed | 5.01e-06 | 143 | 105 | 6 | 22516433 | ||
| Pubmed | 7.38e-06 | 153 | 105 | 6 | 25037231 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RARS1 PUF60 FKBP9 VPS26A TWF1 EIF2S1 ASNS NUP133 RPUSD2 NCOA7 UBE3C USP48 GNL1 PLS3 USP47 WDR44 | 7.57e-06 | 1455 | 105 | 16 | 22863883 |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7682553 | ||
| Pubmed | Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit. | 9.03e-06 | 2 | 105 | 2 | 12463754 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9757574 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15739123 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 4063341 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 34831132 | ||
| Pubmed | Novel genes and mutations in patients affected by recurrent pregnancy loss. | 9.03e-06 | 2 | 105 | 2 | 29016666 | |
| Pubmed | 9.10e-06 | 92 | 105 | 5 | 37343697 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | AMBP PARK7 ANXA11 CP ITIH2 CPNE6 FGA PLAU C8A C9 RAB21 CTSD TNXB | 2.10e-05 | 1070 | 105 | 13 | 23533145 |
| Pubmed | The Ncoa7 locus regulates V-ATPase formation and function, neurodevelopment and behaviour. | 2.11e-05 | 18 | 105 | 3 | 33340069 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | TRIM46 RAP1GAP RARS1 PARK7 MATR3 NBPF26 TARS2 CDK13 ZNF638 CTSD SUCO FBXO21 | 2.36e-05 | 925 | 105 | 12 | 28986522 |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 25648148 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 7513643 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 21507937 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 14597629 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 26728454 | ||
| Pubmed | Cathepsins D and L reduce the toxicity of advanced glycation end products. | 2.70e-05 | 3 | 105 | 2 | 22245096 | |
| Pubmed | cDNA cloning of human inter-alpha-trypsin inhibitor discloses three different proteins. | 2.70e-05 | 3 | 105 | 2 | 3663330 | |
| Pubmed | Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. | 2.70e-05 | 3 | 105 | 2 | 12676526 | |
| Pubmed | 3.00e-05 | 196 | 105 | 6 | 21862448 | ||
| Pubmed | Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. | 5.40e-05 | 4 | 105 | 2 | 2465147 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 20463016 | ||
| Pubmed | Identification of pathogenic T cell epitopes near cathepsin cleavage sites in thyroglobulin. | 5.40e-05 | 4 | 105 | 2 | 23315080 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 19939935 | ||
| Pubmed | Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement. | 5.40e-05 | 4 | 105 | 2 | 3624872 | |
| Pubmed | Expression of cathepsin proteinases by mouse trophoblast in vivo and in vitro. | 5.40e-05 | 4 | 105 | 2 | 10633857 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 16314482 | ||
| Pubmed | [The lysosomal cathepsins B, L and D in development of murine experimental leukemias]. | 5.40e-05 | 4 | 105 | 2 | 20017393 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 18208536 | ||
| Pubmed | Cathepsin L is required for endothelial progenitor cell-induced neovascularization. | 5.40e-05 | 4 | 105 | 2 | 15665831 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 33758261 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 37897947 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 16618117 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.79e-05 | 135 | 105 | 5 | 28675934 | |
| Pubmed | 6.52e-05 | 71 | 105 | 4 | 12754519 | ||
| Pubmed | Little skate genome provides insights into genetic programs essential for limb-based locomotion. | 7.42e-05 | 27 | 105 | 3 | 36288084 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 7.67e-05 | 732 | 105 | 10 | 34732716 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 8.96e-05 | 77 | 105 | 4 | 16944957 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 8938449 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 16873769 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 10551839 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 1385302 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 27997605 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 19293336 | ||
| Pubmed | A molecular network for the transport of the TI-VAMP/VAMP7 vesicles from cell center to periphery. | 8.97e-05 | 5 | 105 | 2 | 22705394 | |
| Pubmed | The genes for the inter-alpha-inhibitor family share a homologous organization in human and mouse. | 8.97e-05 | 5 | 105 | 2 | 1371941 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 9.63e-05 | 607 | 105 | 9 | 39147351 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RARS1 PUF60 PARK7 MATR3 FN3KRP TARS2 EIF2S1 ASNS NUP133 UBE3C CTSD SPEN PLS3 GOLGA4 | 9.93e-05 | 1425 | 105 | 14 | 30948266 |
| Pubmed | 1.14e-04 | 484 | 105 | 8 | 31995728 | ||
| Pubmed | 1.24e-04 | 32 | 105 | 3 | 18842294 | ||
| Pubmed | 1.24e-04 | 32 | 105 | 3 | 23750785 | ||
| Pubmed | 1.25e-04 | 159 | 105 | 5 | 31332168 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 17290288 | ||
| Pubmed | Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. | 1.34e-04 | 6 | 105 | 2 | 22832194 | |
| Pubmed | Biogenesis and proteolytic processing of lysosomal DNase II. | 1.34e-04 | 6 | 105 | 2 | 23516607 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 12036304 | ||
| Pubmed | Human colostrum: identification of minor proteins in the aqueous phase by proteomics. | 1.37e-04 | 162 | 105 | 5 | 16502470 | |
| Pubmed | SEL1L RAP1GAP ERAP1 PARK7 REN TARS2 NEB TLR10 FAT1 ZNF638 USP48 TNXB PLS3 | 1.43e-04 | 1293 | 105 | 13 | 15342556 | |
| Pubmed | SEL1L ZMPSTE24 RARS1 ERAP1 PARK7 FKBP9 JAK1 FAT1 P4HA1 UBE3C RAB21 CTSD PLS3 | 1.47e-04 | 1297 | 105 | 13 | 33545068 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 1.55e-04 | 647 | 105 | 9 | 26618866 | |
| Pubmed | 1.69e-04 | 513 | 105 | 8 | 25798074 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEL1L MPP3 MATR3 FN3KRP VPS26A ASNS NUP133 UBE3C FBXO21 PLS3 USP47 | 1.78e-04 | 974 | 105 | 11 | 28675297 |
| Pubmed | A role for cathepsin E in the processing of mast-cell carboxypeptidase A. | 1.88e-04 | 7 | 105 | 2 | 15860733 | |
| Pubmed | CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. | 1.88e-04 | 7 | 105 | 2 | 30552328 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 8838319 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 12775715 | ||
| Pubmed | Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis. | 1.88e-04 | 7 | 105 | 2 | 17500053 | |
| Pubmed | 1.96e-04 | 175 | 105 | 5 | 28071719 | ||
| Pubmed | Identification and applications of repetitive probes for gene mapping in the mouse. | 2.09e-04 | 38 | 105 | 3 | 1673105 | |
| Pubmed | 2.22e-04 | 401 | 105 | 7 | 25852190 | ||
| Pubmed | 2.34e-04 | 285 | 105 | 6 | 21423176 | ||
| Pubmed | 2.37e-04 | 99 | 105 | 4 | 27746211 | ||
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 19559055 | ||
| Pubmed | A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus. | 2.50e-04 | 8 | 105 | 2 | 1970800 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 28835281 | ||
| Pubmed | 2.73e-04 | 415 | 105 | 7 | 16385451 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RARS1 PUF60 PARK7 MATR3 FN3KRP CDK13 EIF2S1 ZNF638 CTSD GNL1 CTSV PLS3 GOLGA4 | 3.42e-04 | 1415 | 105 | 13 | 28515276 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ZMPSTE24 KIAA0232 VPS26A TARS2 CEMIP2 JAK1 FAT1 FGA PLAU UBE3C RAB21 | 3.69e-04 | 1061 | 105 | 11 | 33845483 |
| Pubmed | 3.79e-04 | 202 | 105 | 5 | 29540532 | ||
| Pubmed | TRIM46 RAP1GAP PARK7 MATR3 FKBP9 TPPP TWF1 SLC8A2 CPNE6 EIF2S1 ATP6V1D FGA PLS3 | 3.81e-04 | 1431 | 105 | 13 | 37142655 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.86e-04 | 313 | 105 | 6 | 38270169 | |
| Pubmed | Expression and localization of Inter-alpha Inhibitors in rodent brain. | 4.00e-04 | 10 | 105 | 2 | 26964679 | |
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 20541250 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RARS1 PUF60 MATR3 ITIH2 TWF1 EIF2S1 NUP133 ZNF638 C9 CTSD SPEN PLS3 | 4.17e-04 | 1257 | 105 | 12 | 36526897 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.73e-04 | 212 | 105 | 5 | 33853758 | |
| Pubmed | 4.88e-04 | 11 | 105 | 2 | 26682926 | ||
| Pubmed | Charcot-Marie-Tooth Neuropathy Type 4 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 4.88e-04 | 11 | 105 | 2 | 20301641 | |
| Pubmed | 4.88e-04 | 11 | 105 | 2 | 12447867 | ||
| Pubmed | A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. | 4.88e-04 | 11 | 105 | 2 | 26647393 | |
| Interaction | CTSB interactions | 3.88e-06 | 242 | 102 | 9 | int:CTSB | |
| Cytoband | 1q21.1 | 1.30e-05 | 62 | 105 | 4 | 1q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 3.46e-04 | 404 | 105 | 6 | chr1q21 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.03e-12 | 23 | 73 | 7 | 662 | |
| GeneFamily | Cathepsins | 2.77e-05 | 15 | 73 | 3 | 470 | |
| GeneFamily | RNA binding motif containing | 1.70e-03 | 213 | 73 | 5 | 725 | |
| GeneFamily | FKBP prolyl isomerases | 2.36e-03 | 18 | 73 | 2 | 910 | |
| GeneFamily | Fibrinogen C domain containing | 4.54e-03 | 25 | 73 | 2 | 554 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.91e-03 | 26 | 73 | 2 | 904 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 5.25e-03 | 87 | 73 | 3 | 372 | |
| Coexpression | NABA_ECM_REGULATORS | 4.31e-07 | 238 | 103 | 9 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 4.96e-07 | 242 | 103 | 9 | MM17062 | |
| Coexpression | HALLMARK_COAGULATION | 1.25e-06 | 138 | 103 | 7 | M5946 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN | 6.29e-06 | 176 | 103 | 7 | M6757 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 9.00e-06 | 71 | 103 | 5 | MM1210 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | SEL1L RARS1 RHOBTB3 MATR3 ETV5 TWF1 EIF2S1 ASNS PLAU UBE3C NBPF14 USP47 | 2.66e-05 | 721 | 103 | 12 | M10237 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | SEL1L RARS1 RHOBTB3 MATR3 AGGF1 TWF1 P4HA1 EIF2S1 ASNS USP47 FKBP14 | 4.66e-05 | 644 | 103 | 11 | M10501 |
| Coexpression | IBRAHIM_NRF2_UP | RARS1 KIAA0232 ETV5 MLH3 ASNS NCOA7 RAB21 SUCO GOLGA4 FKBP14 | 4.83e-05 | 533 | 103 | 10 | M42510 |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_UP | 5.29e-05 | 245 | 103 | 7 | M7300 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 1.00e-04 | 366 | 103 | 8 | M2461 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 1.25e-04 | 378 | 103 | 8 | MM1077 | |
| Coexpression | GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN | 1.38e-04 | 199 | 103 | 6 | M3313 | |
| Coexpression | GSE6681_DELETED_FOXP3_VS_WT_TREG_UP | 1.38e-04 | 199 | 103 | 6 | M6777 | |
| Coexpression | GSE3982_MAST_CELL_VS_NKCELL_UP | 1.38e-04 | 199 | 103 | 6 | M5450 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.42e-04 | 200 | 103 | 6 | M5529 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 1.43e-04 | 67 | 103 | 4 | M1686 | |
| Coexpression | HU_FETAL_RETINA_RPE | 1.54e-04 | 291 | 103 | 7 | M39271 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SH3TC2 TMC7 ERAP1 RHOBTB3 FKBP9 ETV5 CP REN VPS26A CEMIP2 FAT1 P4HA1 ASNS NCOA7 FBXO21 FKBP14 | 2.25e-06 | 880 | 97 | 16 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.90e-07 | 174 | 105 | 7 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.05e-07 | 176 | 105 | 7 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-06 | 166 | 105 | 6 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.44e-06 | 187 | 105 | 6 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.78e-06 | 189 | 105 | 6 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.96e-06 | 190 | 105 | 6 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.12e-06 | 196 | 105 | 6 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-06 | 198 | 105 | 6 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 7.99e-06 | 200 | 105 | 6 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 2.04e-05 | 140 | 105 | 5 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 145 | 105 | 5 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 2.50e-05 | 146 | 105 | 5 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 147 | 105 | 5 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 151 | 105 | 5 | e243b6c76e59035f10519a86399b598dd2123f87 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 151 | 105 | 5 | cdd2ce0969da446616627e3569bbe5a5d9b475bd | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 158 | 105 | 5 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 5.77e-05 | 174 | 105 | 5 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 181 | 105 | 5 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 184 | 105 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.51e-05 | 184 | 105 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 184 | 105 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 184 | 105 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 186 | 105 | 5 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 8.11e-05 | 187 | 105 | 5 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 8.32e-05 | 188 | 105 | 5 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 8.32e-05 | 188 | 105 | 5 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.96e-05 | 191 | 105 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.96e-05 | 191 | 105 | 5 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 192 | 105 | 5 | 8769b67d1cad1be65da3938f916e5bf88f88f6b8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 192 | 105 | 5 | 7af2b5240b1fad2177d8022e5f4fc1fe9e8f03b5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 192 | 105 | 5 | 32e4a180037e516c5cc798cd9dada9385e0f43ae | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.18e-05 | 192 | 105 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 192 | 105 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.41e-05 | 193 | 105 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | 0797245ebfa389a6f66874cb0f11297f1456e600 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | 0241b4b88d6210b4c1b8aa99db17115b18142f01 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.87e-05 | 195 | 105 | 5 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 195 | 105 | 5 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 197 | 105 | 5 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 103 | 105 | 4 | 39d8cfb899ca88c72ebe021d66cc21ae2eb6a1cc | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 103 | 105 | 4 | 01a7baaa0c3903bd00e37717856d2c1ac21bf2c8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 198 | 105 | 5 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 198 | 105 | 5 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.06e-04 | 198 | 105 | 5 | 9b1a58fcf818f9c4ae57bbe99655f0a64fe87df7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 200 | 105 | 5 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 200 | 105 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 200 | 105 | 5 | ce012d738cbec1afdd6af0e10e94b2b6c17b036e | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 200 | 105 | 5 | df90b67490cd649de3e3a713762ffbc34a698899 | |
| ToppCell | distal-Epithelial-Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 200 | 105 | 5 | 5c14f0c09bb8b3daf6d649032e888a7880c52b73 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Drug | phenylmethylsulfonyl fluoride | 2.64e-06 | 263 | 101 | 9 | CID000004784 | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.87e-06 | 198 | 101 | 8 | 4837_DN | |
| Drug | E64A | 1.05e-05 | 31 | 101 | 4 | CID000173548 | |
| Drug | guanidinium | 1.37e-05 | 245 | 101 | 8 | CID000003520 | |
| Drug | AC1NRA23 | 1.84e-05 | 73 | 101 | 5 | CID005287657 | |
| Drug | pMEU | 1.95e-05 | 2 | 101 | 2 | CID000451930 | |
| Drug | Om-00-3 | 1.95e-05 | 2 | 101 | 2 | CID000447068 | |
| Drug | CD564 | 1.95e-05 | 2 | 101 | 2 | CID000002605 | |
| Drug | AcDMH | 1.95e-05 | 2 | 101 | 2 | CID003035957 | |
| Drug | Cgp 44099 | 1.95e-05 | 2 | 101 | 2 | CID000131035 | |
| Drug | Es 1005 | 1.95e-05 | 2 | 101 | 2 | CID003082723 | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; HL60; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 2519_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 7034_DN | |
| Drug | AC1NUJRK | 3.71e-05 | 15 | 101 | 3 | CID005480852 | |
| Drug | S-2648 | 5.62e-05 | 47 | 101 | 4 | CID000123687 | |
| Drug | midodrine | 5.62e-05 | 47 | 101 | 4 | CID000004195 | |
| Drug | Pd 132002 | 5.83e-05 | 3 | 101 | 2 | CID005487417 | |
| Drug | Cgp 38560a | 5.83e-05 | 3 | 101 | 2 | CID005487223 | |
| Drug | AC1NUZ8A | 5.83e-05 | 3 | 101 | 2 | CID005464453 | |
| Drug | AC1NAP6W | 5.83e-05 | 3 | 101 | 2 | CID004480500 | |
| Drug | AC1LA3FP | 5.83e-05 | 3 | 101 | 2 | CID000480798 | |
| Drug | S 2864 | 5.83e-05 | 3 | 101 | 2 | CID000192484 | |
| Drug | Hexapeptide 5 | 5.83e-05 | 3 | 101 | 2 | CID000194955 | |
| Drug | 3,4-didehydroretinoic acid | 6.59e-05 | 18 | 101 | 3 | CID000447276 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.08e-04 | 139 | 99 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | response to bronchodilator, response to corticosteroid | 1.11e-04 | 5 | 99 | 2 | GO_0031960, GO_0097366 | |
| Disease | Ischemia | 1.13e-04 | 28 | 99 | 3 | C0022116 | |
| Disease | Drug toxicity | 1.87e-04 | 84 | 99 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.87e-04 | 84 | 99 | 4 | C0041755 | |
| Disease | squamous cell lung carcinoma | 2.41e-04 | 165 | 99 | 5 | EFO_0000708 | |
| Disease | sulfatase-modifying factor 1 measurement | 3.08e-04 | 8 | 99 | 2 | EFO_0802098 | |
| Disease | Pulmonary Thromboembolisms | 7.20e-04 | 12 | 99 | 2 | C0524702 | |
| Disease | adult respiratory distress syndrome (is_implicated_in) | 7.20e-04 | 12 | 99 | 2 | DOID:11394 (is_implicated_in) | |
| Disease | Pulmonary Embolism | 7.20e-04 | 12 | 99 | 2 | C0034065 | |
| Disease | colorectal cancer (is_implicated_in) | 7.50e-04 | 121 | 99 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Calcium channel blocker use measurement | 7.72e-04 | 213 | 99 | 5 | EFO_0009930 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 8.48e-04 | 13 | 99 | 2 | cv:C4082197 | |
| Disease | Psoriasis | 9.40e-04 | 57 | 99 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 9.40e-04 | 57 | 99 | 3 | C0030246 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 9.88e-04 | 14 | 99 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 9.88e-04 | 14 | 99 | 2 | DOID:3969 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 1.12e-03 | 616 | 99 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.12e-03 | 616 | 99 | 8 | C0376358 | |
| Disease | Osteoporosis, Age-Related | 1.14e-03 | 61 | 99 | 3 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 1.14e-03 | 61 | 99 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 1.14e-03 | 61 | 99 | 3 | C0029459 | |
| Disease | Osteoporosis | 1.26e-03 | 63 | 99 | 3 | C0029456 | |
| Disease | Antibody Deficiency Syndrome | 1.47e-03 | 17 | 99 | 2 | C0003257 | |
| Disease | Hemorrhage | 2.04e-03 | 20 | 99 | 2 | C0019080 | |
| Disease | Drug-Induced Liver Disease | 2.44e-03 | 404 | 99 | 6 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 2.44e-03 | 404 | 99 | 6 | C3658290 | |
| Disease | Chemical and Drug Induced Liver Injury | 2.44e-03 | 404 | 99 | 6 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 2.44e-03 | 404 | 99 | 6 | C1262760 | |
| Disease | Hepatitis, Toxic | 2.44e-03 | 404 | 99 | 6 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 2.44e-03 | 404 | 99 | 6 | C4279912 | |
| Disease | small cell lung carcinoma | 2.50e-03 | 80 | 99 | 3 | EFO_0000702 | |
| Disease | Immunologic Deficiency Syndromes | 2.69e-03 | 23 | 99 | 2 | C0021051 | |
| Disease | Albuminuria | 2.93e-03 | 24 | 99 | 2 | C0001925 | |
| Disease | migraine disorder, Headache | 3.06e-03 | 86 | 99 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | Ataxia | 3.18e-03 | 25 | 99 | 2 | C0004134 | |
| Disease | Malignant neoplasm of breast | TRIML1 RAP1GAP RARG KCNT2 GUCY2F NUP133 ZNF432 MMP10 SPEN PLS3 | 3.27e-03 | 1074 | 99 | 10 | C0006142 |
| Disease | Kidney Diseases | 3.27e-03 | 88 | 99 | 3 | C0022658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAYEKTDTDGKFLYH | 96 | P02760 | |
| GSDELTQGYIYFHKA | 366 | P08243 | |
| LYHDISGDTSGDYRK | 481 | P50995 | |
| DGSVSYTGFHLEYKA | 1681 | Q7Z407 | |
| AKFINDYGTHYITSG | 331 | P07357 | |
| DAGHSSFQFYKSGIY | 251 | O60911 | |
| YKHSNGSYSAFGERD | 1016 | A8K2U0 | |
| GFSYDENTGLYFDHS | 206 | Q8N302 | |
| LLGSYSDLHYGFLED | 176 | Q6MZZ7 | |
| GDTYVSTSDYKDNFG | 1326 | Q14004 | |
| LVYDYDSSGKHDFIG | 226 | O95741 | |
| SEVTGHSKGYGFVEY | 176 | Q9HCJ3 | |
| EAESYAESVGAKHYH | 146 | Q9UL25 | |
| FVCNDKSSGYHYGVS | 91 | P13631 | |
| KDGSYHEDVGYGVSE | 116 | P43351 | |
| HIYSGTLMDYKDDEG | 596 | P23458 | |
| LNEEGHYIYVDTSFG | 46 | Q7Z304 | |
| SHGITYYKEHEGAIY | 121 | P00450 | |
| SFAVKEHGDFYSFDG | 161 | P09238 | |
| ADIGTNGEFYYSFKD | 176 | Q14517 | |
| DVGRYFSEFTGTHYI | 581 | O94952 | |
| HYEGYLEKDGSLFHS | 51 | Q9NWM8 | |
| YTEAFVDSGGDKTYS | 196 | Q8WUM0 | |
| YHSNSGKEEGFELYS | 106 | Q96FN9 | |
| GHAGTIYKDFVYISG | 436 | Q8N4N3 | |
| FGETSHNYHKFDSEY | 236 | P43243 | |
| NSGKGFIDGHYKDYF | 921 | P19823 | |
| ASFYGHSEYELAIAG | 236 | Q9HA64 | |
| YYDSGEDTSCKGHID | 1776 | Q86WG5 | |
| YKGGNLYHTDVSLFG | 2156 | Q13439 | |
| FGKHSGIVTSYDYDA | 356 | Q8NCI6 | |
| GYGAYDAFKHAVSDP | 146 | P05198 | |
| YAGNLSETFHGFYKS | 151 | Q9NZ08 | |
| DTSEGAVHYFYDESG | 656 | Q9H6A9 | |
| GTQHSYSEEEKYAFV | 116 | P13797 | |
| EGHYYGKSELESGKF | 1161 | Q92628 | |
| KEFELSGYISSEAHY | 231 | Q9UHC1 | |
| GGHYTYSENRVEKDG | 136 | Q99497 | |
| YGEYKGHLYGTSVDA | 496 | Q96JB8 | |
| SFQDYLGKIHGAYSS | 151 | P36915 | |
| GYFSSSHEGFSYEKD | 316 | P41161 | |
| AEYEGKSFTYASFHA | 501 | Q6UVM3 | |
| YNLFASGEGDYSTRH | 486 | P13674 | |
| DNGSKGYAYVHFDSL | 141 | Q96DU9 | |
| DYETHGAGFSIRYEI | 126 | O14786 | |
| YHYNGTFLDGTLFDS | 171 | O95302 | |
| VNTFDEKSYYESHLG | 301 | Q9NZC3 | |
| YVKNGTSFDIHYGSG | 131 | P07339 | |
| GSHDVYKVETIGDAY | 921 | P51841 | |
| KHGGELYFSDVYTSL | 176 | Q9HBK9 | |
| GGYGHTSVYDEITKS | 466 | Q5VV63 | |
| DVDYKGGYRHATFVD | 556 | Q9UHN6 | |
| HDIDGSVTGYKDAYV | 951 | Q9UHN6 | |
| AYAEYHFRVGSEAEG | 736 | P02671 | |
| EGSKRSSHSNAYFYG | 256 | O75844 | |
| EKGEYFAFLETYGTH | 331 | P02748 | |
| HSLDDFYIGKYFGGV | 176 | O94955 | |
| FLEHGEYKENLYGTS | 451 | Q13368 | |
| GKEEAYRGYGSHTAN | 1011 | Q7Z2Y5 | |
| EHFAETSYYFEGGLR | 126 | Q8IZ73 | |
| STEYGFYHDFFLGKE | 156 | Q9BW92 | |
| VKSDGGYTYDTSDLA | 376 | P54136 | |
| KAGYGEYSEDVHLHT | 511 | Q7Z4K8 | |
| YEGNGHFYRGKASTD | 71 | P00749 | |
| HKGYGFIEYEKAQSS | 266 | Q9UHX1 | |
| FGGKAYLDHNSFDYS | 281 | Q9BXR5 | |
| IKLGDYHFYGFGTDV | 631 | Q9UBV2 | |
| FKFSDHYYGTGETFL | 851 | Q8NI08 | |
| YGSSFYALEEKHVGF | 771 | Q3BBV2 | |
| YGSSFYALEEKHVGF | 806 | P0DPF3 | |
| YGSSFYALEEKHVGF | 806 | Q6P3W6 | |
| YGSSFYALEEKHVGF | 2026 | Q6P3W6 | |
| YGSSFYALEEKHVGF | 3246 | Q6P3W6 | |
| YGSSFYALEEKHVGF | 466 | Q5TI25 | |
| YGSSFYALEEKHVGF | 1511 | A0A087WUL8 | |
| YGSSFYALEEKHVGF | 2731 | A0A087WUL8 | |
| YGSSFYALEEKHVGF | 191 | P0DPF2 | |
| YGSSFYALEEKHVGF | 1411 | P0DPF2 | |
| YGSSFYALEEKHVGF | 2631 | P0DPF2 | |
| YGSSFYALEEKHVGF | 3851 | P0DPF2 | |
| YGSSFYALEEKHVGF | 5071 | P0DPF2 | |
| YGSSFYALEEKHVGF | 766 | B4DH59 | |
| FHLGGKEYTLTSADY | 336 | P00797 | |
| GKEHFNYYSLDAALG | 96 | P47736 | |
| HEGYADHFKSLYDFS | 476 | Q8TF17 | |
| LLDSRGAFHTKGYYA | 506 | Q15477 | |
| GAFHTKGYYAAVEAK | 511 | Q15477 | |
| HSGFSIKGYSAYDFS | 211 | P43234 | |
| HYSYGVKDTDKGEVS | 66 | A0A0K0K1G6 | |
| VHSSGELFQEYRYGD | 3296 | Q96T58 | |
| IGSDKGCSQYFYAEH | 241 | Q7RTY8 | |
| HYHEGTDSYELTGLA | 111 | Q9Y5K8 | |
| SDHRYLVTLYGFSDG | 1941 | P22105 | |
| GGHYYACIKSFSDEQ | 501 | Q96K76 | |
| GDFFISSKDLGYDYS | 436 | P14679 | |
| HDFTYLVSGSEDKYV | 796 | Q5JSH3 | |
| DFSNMGEVYHSSYKG | 1146 | Q9UBS9 | |
| HYSYGVNSTEKGDLS | 66 | P0DTU4 | |
| LDYESGHIAFYNGTD | 411 | Q8N9V2 | |
| VDESGYVSGYKHAGT | 196 | O94811 | |
| VEKHYLFYDGESVSG | 36 | O75436 | |
| DGKSFLHGNYEELYS | 161 | O94892 | |
| SKLGGYFTAVYADEH | 1801 | Q96JM2 | |
| HYSYGVNSTEKGDLS | 66 | A0A075B6N4 | |
| YVEHKGGSYVYELSA | 326 | Q86UV5 | |
| YGHASKYGYTEDPLE | 211 | Q14966 | |
| GSKEHGGFLYVTSTY | 1026 | O95405 | |
| YKHSHEGDYLESIVF | 241 | Q12792 | |
| EETSLFYGHYTIDGV | 241 | Q7Z402 | |
| LKSFTNYSGGYSADH | 976 | Q15386 | |
| TKSFYEGAAEYVSHE | 586 | A8MPX8 | |
| GTYTFSDGLHYDEKN | 66 | Q5VZ52 | |
| YRTEDGSAKAGSDYE | 431 | Q9UPR5 | |
| HYAGEVTYCTKGFLE | 516 | Q8N1T3 | |
| YSDGGVFAVSTAYKH | 6566 | P20929 |